Managing Gout in the Clinic: Pearls for Family Medicine Specialists

Authors

  • Shelly Dunne, MD Michael Garron Hospital, Toronto, ON

DOI:

https://doi.org/10.58931/cpct.2025.3246

Abstract

Gout is the most common form of inflammatory arthritis worldwide, often presenting diagnostic and management challenges. However, it can also be gratifying to treat, as successful treatment provides relief from an extremely painful arthritis, and proper preventive strategies can lead to a gout free future. We will begin with a case from my clinical practice.

Author Biography

Shelly Dunne, MD, Michael Garron Hospital, Toronto, ON

Dr. Shelly M. Dunne graduated from Memorial University of Newfoundland School of Medicine in 1993. She did Internal Medicine training at University of Toronto, followed by a fellowship in Rheumatology. She has been in private rheumatology practice in Toronto since 1998. She is also affiliated with Michael Garron Hospital as a consulting rheumatologist.  She has a busy general rheumatology practice seeing the full range of rheumatologic illness with a special interest in inflammatory disease and gout.

References

Fitzgerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles A, et al. 2020 American College of Rheumatology Guideline for the management of gout. [published correction appears in Arthritis Care Res (Hoboken). 2020;72(8):1187. doi: 10.1002/acr.24401.] [published correction appears in Arthritis Care Res (Hoboken). 2021 Mar;73(3):458. doi: 10.1002/acr.24566.]. Arthritis Care Res (Hoboken). 2020;72(6):744-760. doi:10.1002/acr.24180 DOI: https://doi.org/10.1002/acr.24180

Kwok TSH, Xu VYY, Lake SL. Gout. CMAJ. 2021;193(5):E171. doi: 10.1503/cmaj.201392 DOI: https://doi.org/10.1503/cmaj.201392

Clebak KT, Morrison A, Croad JR. Gout rapid evidence review. Am Fam Physician. 2020;102(9):533-538.

White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018;378(13):1200-1210. doi:10.1056/NEJMoa1710895 DOI: https://doi.org/10.1056/NEJMoa1710895

Mackenzie IS, Ford I, Nuki G, Hallas J, Hawkey CJ, Webster J, et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet. 2020;396(10264):1745-1757. doi:10.1016/S0140-6736(20)32234-0 DOI: https://doi.org/10.1016/S0140-6736(20)32234-0

Keller SF, Lu N, Blumenthal KG, Rai SK, Yokose C, Choi JWJ, et al. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018;77(8):1187-1193. doi:10.1136/annrheumdis-2017-212905 DOI: https://doi.org/10.1136/annrheumdis-2017-212905

Downloads

Published

2025-08-26

How to Cite

1.
Dunne S. Managing Gout in the Clinic: Pearls for Family Medicine Specialists. Can Prim Care Today [Internet]. 2025 Aug. 26 [cited 2025 Sep. 6];3(2):28–32. Available from: https://canadianprimarycaretoday.com/article/view/3-2-Dunne

Issue

Volume 3, Issue 2, Summer 2025

Section

Articles

License

Copyright (c) 2025 Canadian Primary Care Today

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.